Navin Fluorine shares jump 5.5% after Q2 profit soars 82% YoY to ₹269 crore, dividend declared
Navin Fluorine's EBITDA climbed 65.9% to ₹408 crore, with margins expanding 190 basis points to 34.3%. Navin Fluorine also declared an interim dividend of ₹8 per share.

Shares of Navin Fluorine International rose over 5.5% on Friday, October 30, after the company reported a strong set of results for the September quarter of FY27, with consolidated net profit jumping 81.8% year-on-year to ₹269 crore, compared with ₹148 crore in the corresponding quarter last year.Revenue from operations increased 57.1% YoY to ₹1,191 crore in Q2 FY27, against ₹758 crore in the year-ago period.The company's earnings before interest, tax, depreciation and amortisation rose 65.9% to ₹408 crore from ₹246 crore a year ago. EBITDA margin also improved by 190 basis points to 34.3%, compared with 32.4% in the corresponding quarter last year.On a sequential basis, Navin Fluorine's revenue grew 14% from ₹1,045 crore in the June quarter. Net profit increased 10.7% from ₹243 crore, while EBITDA rose 14.3% from ₹357 crore.EBITDA margin expanded marginally by 10 basis points to 34.3% from 34.2% in the preceding quarter.The company's board of directors has declared an interim dividend of ₹8 per equity share of face value ₹2 each, translating into a payout of 400% for FY27.As per the exchange filing, November 5, 2026, has been fixed as the record date to determine shareholders eligible for the interim dividend. The dividend will be paid on or after November 26, 2026.The company also disclosed that the group had recognised a liability of ₹6.75 crore for the year ended March 31, 2026, as an exceptional item following the implementation of the new Labour Codes.The stock has gained 5.8% over the past month and is up 47% so far this calendar year.Also Read: Max Healthcare Q2 results: Higher patient volumes lift revenue 20%, profit rises 10% to ₹448 crore
Related Stories

Fusion CX shares in focus as UK unit inks deal to acquire German BPO group for European expansion
The acquisition's upfront cash consideration and the fix purchase price has been set at €2 million , of which, €1.98 million to impacx Holding GmbH and €13,000 to Sack.

P&G Hygiene and Health Care Q2 results: Key parameters lower from last year, stock declines
Procter & Gamble Hygiene and Health Care's Q2 EBITDA declined 8.8% to ₹260 crore from ₹285 crore in the prior fiscal. Its EBITDA margin contracted to 22.7% from 24.8% in the year-ago period.

HAL shares: Cheapest pure play defence stock a buy? CLSA says best is yet to come -
CLSA said HAL is the biggest beneficiary of the government's Make in India push, adding that the best is yet to come in terms of multi-billion-dollar projects.
